Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Miravitlles

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
The European Respiratory Journal|April 24, 2009
Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPDM Miravitlles, A Marín, E Monsó, et al.
Respiratory Research|January 30, 2019
Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspectiveM T Driessen, J Whalen, B Seewoodharry Buguth, et al.
Respiratory Research|November 22, 2018
Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspectiveM T Driessen, J Whalen, B Seewoodharry Buguth, et al.
The European Respiratory Journal|January 3, 2006
Epidemiology and costs of chronic obstructive pulmonary diseaseK R Chapman, D M Mannino, J B Soriano, et al.
Archivos De Bronconeumologia|January 29, 2003
[Accreditation requirements for educational programs in respiratory medicine]J L Alvarez-Sala, F Sánchez Gascón, A Agustí, et al.
The European Respiratory Journal|December 10, 2009
Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007J B Soriano, J Ancochea, M Miravitlles, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 8, 2021
Severe loss of mechanical efficiency in COVID-19 patientsEulogio Pleguezuelos, Amin Del Carmen, Gemma Llorensi, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|January 15, 2020
Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion documentE Bouza, A Alvar, P Almagro, et al.
Archivos De Bronconeumologia|September 20, 2001
[ALAT (Latin American Thoracic Association) recommendations on community-acquired pneumonia]C M Luna, J Ramírez, H López, et al.
The European Respiratory Journal|February 2, 2008
Outcomes for COPD pharmacological trials: from lung function to biomarkersM Cazzola, W MacNee, F J Martinez, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
The European Respiratory Journal|April 24, 2009
Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPDM Miravitlles, A Marín, E Monsó, et al.
Respiratory Research|January 30, 2019
Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspectiveM T Driessen, J Whalen, B Seewoodharry Buguth, et al.
Respiratory Research|November 22, 2018
Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspectiveM T Driessen, J Whalen, B Seewoodharry Buguth, et al.
The European Respiratory Journal|January 3, 2006
Epidemiology and costs of chronic obstructive pulmonary diseaseK R Chapman, D M Mannino, J B Soriano, et al.
Archivos De Bronconeumologia|January 29, 2003
[Accreditation requirements for educational programs in respiratory medicine]J L Alvarez-Sala, F Sánchez Gascón, A Agustí, et al.
The European Respiratory Journal|December 10, 2009
Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007J B Soriano, J Ancochea, M Miravitlles, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 8, 2021
Severe loss of mechanical efficiency in COVID-19 patientsEulogio Pleguezuelos, Amin Del Carmen, Gemma Llorensi, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|January 15, 2020
Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion documentE Bouza, A Alvar, P Almagro, et al.
Archivos De Bronconeumologia|September 20, 2001
[ALAT (Latin American Thoracic Association) recommendations on community-acquired pneumonia]C M Luna, J Ramírez, H López, et al.
The European Respiratory Journal|February 2, 2008
Outcomes for COPD pharmacological trials: from lung function to biomarkersM Cazzola, W MacNee, F J Martinez, et al.
Pageof 13